DOW JONES23,140.68+460.69 2.03%
S&P 5002,713.46+49.78 1.87%
NASDAQ7,973.64+60.40 0.76%

SunTrust Robinson Humphrey Initiates Coverage On NextCure with Buy Rating, Announces $78 Price Target

SunTrust Robinson Humphrey analyst Asthika Goonewardene initiates coverage on NextCure (NASDAQ:NXTC) with a Buy rating and a $78 price target.

Benzinga · 01/13/2020 13:52

SunTrust Robinson Humphrey analyst Asthika Goonewardene initiates coverage on NextCure (NASDAQ:NXTC) with a Buy rating and a $78 price target.